Australia-based Creso Pharma Ltd. said it launched a line of CBD-based powdered instant tea products in Switzerland with plans to move into Germany soon.
Creso said it will leverage an established distribution network throughout Switzerland in support of the brand, CannaQIX, after having completed all necessary legal and regulatory due diligence to put the products on the market.
That sales network comprises more than 2,100 points of sale in pharmacies, drugstores, health nutrition shops and large retail groups including leading department store chain Manor. Creso also supplies all major wholesalers in Switzerland including Galexis, Amedis and Voigt, the company said.
Plans for Germany
Creso said a recent decision by the German Federal Court of Justice to annul previous charges against hemp tea sellers in Braunschweig puts the company in a position to actively market and sell its hemp tea products in Germany without any further regulatory approvals.
That case, which ultimately paved the way for the sale of food products based on hemp flowers and leaves on the German market, had delayed launch of Creso’s products in Germany, which had been scheduled for the second half of 2020, the company said.
The new instant teas were developed based on technology that optimizes the CBD content and improves taste. Creso said the technology will also be used to develop a line of cannaQIX-branded lozenges the company plans.
Creso said it is studying the legal landscape in other European markets ahead of further expansion across the continent.
